(19)
(11) EP 4 514 831 A1

(12)

(43) Date of publication:
05.03.2025 Bulletin 2025/10

(21) Application number: 23797304.5

(22) Date of filing: 27.04.2023
(51) International Patent Classification (IPC): 
C07K 14/705(2006.01)
A61P 25/30(2006.01)
A61K 38/17(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 25/30; C07K 14/70571; A61K 38/00; A61K 48/005; C12N 5/0619; C12N 2510/00; C12N 2750/14143; C12N 2503/02
(86) International application number:
PCT/US2023/020251
(87) International publication number:
WO 2023/212230 (02.11.2023 Gazette 2023/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 27.04.2022 US 202263335249 P

(71) Applicant: Howard Hughes Medical Institute
Chevy Chase, Maryland 20815-6789 (US)

(72) Inventors:
  • STERNSON, Scott
    Chevy Chase, Maryland 20815-6789 (US)
  • MAGNUS, Christopher
    Chevy Chase, Maryland 20815-6789 (US)

(74) Representative: Bassil, Nicholas Charles 
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) CHEMOGENETIC RECEPTORS AND METHODS OF MAKING AND USING